8 followers
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet ag... Read more
Laurent Fischer
Invivyd
1 follower
Abeona Therapeutics
1 follower
Annexon Biosciences
2 followers
Immunai
2 followers
Thermo Fisher Scientific
155 followers
Agilent Technologies
63 followers
Myriad Genetics
35 followers
bluebird bio
38 followers
Exact Sciences
15 followers
Natera
13 followers
Charles River Laboratories
10 followers
Explore companies